ALVYMRO Trademark

Trademark Overview


On Friday, March 3, 2023, a trademark application was filed for ALVYMRO with the United States Patent and Trademark Office. The USPTO has given the ALVYMRO trademark a serial number of 97821393. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Glaxo Group Limited. The ALVYMRO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
alvymro

General Information


Serial Number97821393
Word MarkALVYMRO
Filing DateFriday, March 3, 2023
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7338265
Registration DateTuesday, March 26, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023ASSIGNED TO EXAMINER
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 7, 2023NEW APPLICATION ENTERED